Clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2020
-
- Takahiro Nakazawa
- Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical Sciences Nagoya Japan
-
- Terumi Kamisawa
- Department of Internal Medicine Tokyo Metropolitan Komagome Hospital Tokyo Japan
-
- Kazuichi Okazaki
- Department of Internal Medicine Kansai Medical University Kori Hospital Neyagawa Japan
-
- Shigeyuki Kawa
- Department of Internal Medicine Matsumoto Dental University Shiojiri Japan
-
- Susumu Tazuma
- Department of General Internal Medicine Hiroshima University Graduate School of Biomedical & Health Science Hiroshima Japan
-
- Takayoshi Nishino
- Department of Gastroenterology Tokyo Womens’ Medical University Yachiyo Medical Center Yachiyo Japan
-
- Dai Inoue
- Department of Radiology Kanazawa University Graduate School of Medical Sciences Kanazawa Japan
-
- Itaru Naitoh
- Department of Gastroenterology and Metabolism Nagoya City University Graduate School of Medical Sciences Nagoya Japan
-
- Takayuki Watanabe
- Department of Medicine, Gastroenterology Shinshu University Matsumoto, Nagano Japan
-
- Kenji Notohara
- Department of Anatomic Pathology Kurashiki Central Hospital Kurashiki Japan
-
- Kensuke Kubota
- Department of Endoscopy Yokohama City University Hospital Yokohama Japan
-
- Hirotaka Ohara
- Department of Community‐Based Medical Education Nagoya City University Graduate School of Medical Sciences Nagoya Japan
-
- Atsushi Tanaka
- Department of Medicine Teikyo University School of Medicine Tokyo Japan
-
- Hajime Takikawa
- Department of Medicine Teikyo University School of Medicine Tokyo Japan
-
- Atsushi Masamune
- Division of Gastroenterology Tohoku University Graduate School of Medicine Sendai Japan
-
- Michiaki Unno
- Division of Hepato‐Biliary Pancreatic Surgery Tohoku University Graduate School of Medicine Sendai Japan
書誌事項
- タイトル別名
-
- (Revision of the clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2012)
説明
<jats:title>Abstract</jats:title><jats:p>Several years have passed since the clinical diagnostic criteria for IgG4‐related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then.</jats:p><jats:p>The Research Committees for IgG4‐related Diseases and for Intractable Diseases of the Liver and Biliary Tract, in association with the Ministry of Health, Labor, and Welfare of Japan and the Japan Biliary Association, have established a working group consisting of researchers specializing in IgG4‐SC and have drawn up new clinical diagnostic criteria for IgG4‐SC 2020.</jats:p><jats:p>The diagnosis of IgG4‐SC is based on a combination of the following six criteria: (a) narrowing of the intra‐ or extrahepatic bile duct; (b) thickening of the bile duct wall; (c) serological findings; (d) pathological findings; (e) other organ involvement; and (f) effectiveness of steroid therapy.</jats:p><jats:p>These new diagnostic criteria for IgG4‐SC are useful in practice for general physicians and other non‐specialists.</jats:p>
収録刊行物
-
- Journal of Hepato-Biliary-Pancreatic Sciences
-
Journal of Hepato-Biliary-Pancreatic Sciences 28 (3), 235-242, 2021-02-26
Wiley
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1360572092561743616
-
- DOI
- 10.1002/jhbp.913
-
- ISSN
- 18686982
- 18686974
-
- データソース種別
-
- Crossref
- KAKEN